Clinical Trials Browser

Stomach Neoplasms

Stomach Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Nasopharyngeal Carcinoma

EGFR Positive Non-small Cell Lung Cancer

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Non-Squamous Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Digestive System Neoplasms

Squamous Cell Carcinoma of Head and Neck

Stomach Neoplasms

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

HER2-positive Breast Cancer

Hypopharyngeal Neoplasms

Breast Neoplasms

Head and Neck Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

Breast Neoplasms

Metastatic Castration-resistent Prostate Cancer

Pancreatic Neoplasms

Sinonasal Tumors

Unresectable Sinonasal Tumors

Nasopharyngeal Carcinoma

Gastric Adenocarcinoma

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Hormone Sensitive Metastatic Prostate Cancer

Platinum-resistant Recurrent Ovarian Cancer

Carcinoma, Squamous Cell

Advanced Malignant Tumors

Breast Neoplasms

Breast Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Breast Neoplasms

Esophageal Squamous Cell Carcinoma

Prostatic Neoplasms

Stomach Neoplasms

Breast Neoplasms

Breast Neoplasms

Clinical Trials

IMAGINE

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)

SAVE

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

ALTER-G-001

CZCNRHNSCC

LOTS

CLOVER

B2023-153

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer

NCCCNRHNSCC

Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

HIST-RIC

Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer

Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

easy laugh

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

CHANCE

A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer

An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma

HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors

Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer